STEM, INC. current report, 26 October 2023

SEC Filing Summary

Business Context and Reporting Period

Stem, Inc. filed a Form 8-K under Item 5.02(d) to report the appointment of Ira Birns to its Board of Directors and as chairman of the Audit Committee. The report date was October 26, 2023; the appointments became effective November 6, 2023. The filing does not address a quarterly or annual financial reporting period.

Financial and Operating Metrics

The filing text does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.

Material Changes Versus Prior Period

  • Mr. Birns was appointed as a Class II director.
  • Mr. Birns was appointed chairman of the Audit Committee.
  • The Board determined that Mr. Birns meets applicable NYSE and SEC Audit Committee requirements and qualifies as an SEC “audit committee financial expert.”
  • He is expected to enter into the Company’s standard non-employee director indemnification agreement.
  • The Board approved a pro-rated grant of 13,836 restricted stock units, vesting in full on June 7, 2024.

Guidance, Outlook, Risks, and Unusual Items

No financial guidance, business outlook, material contingencies, or specific risk disclosures are provided in the filing.

Mr. Birns will receive pro-rated compensation consistent with other non-employee directors. The filing states that neither Mr. Birns nor his immediate family members has a reportable material interest in transactions involving the Company under Item 404(a) of Regulation S-K.

The filing references a press release furnished as Exhibit 99. The filing text identifies the exhibit as dated October 31, 2023, although the Form 8-K was signed November 6, 2023.

Investor Verification Items

  • Verify the effective date of the Board and Audit Committee appointments.
  • Review the referenced Exhibit 99 press release for additional biographical or governance information.
  • Confirm the terms and accounting treatment of the 13,836 restricted stock unit grant.
  • Review the Company’s proxy statement for the applicable non-employee director compensation terms.
  • Use the Company’s latest periodic filing to assess financial performance, liquidity, debt, and business outlook, as those matters are not covered here.